Asset Management One’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$72.7M Sell
2,590,740
-149,313
-5% -$3.98M 0.21% 86
2025
Q4
$68.5M Buy
2,740,053
+8,845
+0.3% +$223K 0.19% 98
2025
Q3
$69.6M Buy
2,731,208
+201,962
+8% +$4.98M 0.2% 93
2025
Q2
$61.3M Sell
2,529,246
-26,782
-1% -$625K 0.19% 97
2025
Q1
$64.8M Buy
2,556,028
+163,269
+7% +$4.27M 0.22% 88
2024
Q4
$63.7M Buy
2,392,759
+114,090
+5% +$3.09M 0.22% 83
2024
Q3
$65.9M Buy
2,278,669
+39,464
+2% +$1.15M 0.23% 81
2024
Q2
$62.7M Sell
2,239,205
-166,440
-7% -$4.58M 0.24% 80
2024
Q1
$66.8M Sell
2,405,645
-168,100
-7% -$4.66M 0.26% 73
2023
Q4
$74.1M Sell
2,573,745
-62,456
-2% -$1.89M 0.3% 63
2023
Q3
$87.4M Sell
2,636,201
-24,337
-0.9% -$861K 0.39% 42
2023
Q2
$97.6M Buy
2,660,538
+60,622
+2% +$2.36M 0.41% 40
2023
Q1
$106M Buy
2,599,916
+23,044
+0.9% +$995K 0.48% 37
2022
Q4
$132M Sell
2,576,872
-61,125
-2% -$2.93M 0.64% 23
2022
Q3
$115M Sell
2,637,997
-46,358
-2% -$2.25M 0.59% 27
2022
Q2
$141M Sell
2,684,355
-69,442
-3% -$3.54M 0.66% 22
2022
Q1
$143M Sell
2,753,797
-118,632
-4% -$6.16M 0.56% 24
2021
Q4
$166M Buy
2,872,429
+1,586
+0.1% +$78.6K 0.58% 21
2021
Q3
$123M Sell
2,870,843
-40,720
-1% -$1.8M 0.47% 31
2021
Q2
$114M Sell
2,911,563
-6,314
-0.2% -$246K 0.42% 37
2021
Q1
$106M Sell
2,917,877
-89,266
-3% -$3.17M 0.42% 42
2020
Q4
$111M Sell
3,007,143
-160,250
-5% -$5.88M 0.46% 37
2020
Q3
$110M Sell
3,167,393
-146,484
-4% -$5.14M 0.51% 36
2020
Q2
$103M Sell
3,313,877
-89,507
-3% -$3.04M 0.51% 36
2020
Q1
$105M Sell
3,403,384
-24,914
-0.7% -$849K 0.62% 30
2019
Q4
$127M Sell
3,428,298
-64,534
-2% -$2.3M 0.57% 30
2019
Q3
$119M Buy
3,492,832
+25,966
+0.7% +$944K 0.57% 34
2019
Q2
$142M Buy
3,466,866
+193,762
+6% +$7.69M 0.7% 24
2019
Q1
$132M Sell
3,273,104
-7,421,586
-69% -$297M 0.71% 22
2018
Q4
$442M Sell
10,694,690
-73,742
-0.7% -$3.06M 1.05% 11
2018
Q3
$450M Sell
10,768,432
-15,784
-0.1% -$608K 0.92% 13
2018
Q2
$371M Buy
10,784,216
+416,105
+4% +$14.2M 0.81% 23
2018
Q1
$349M Buy
10,368,111
+226,056
+2% +$7.77M 0.79% 21
2017
Q4
$349M Sell
10,142,055
-124,847
-1% -$4.26M 0.77% 24
2017
Q3
$348M Buy
10,266,902
+74,971
+0.7% +$2.41M 0.82% 20
2017
Q2
$325M Sell
10,191,931
-198,751
-2% -$6.27M 0.83% 18
2017
Q1
$337M Sell
10,390,682
-941,266
-8% -$29.7M 0.89% 18
2016
Q4
$349M Buy
11,331,948
+9,704,301
+596% +$296M 0.89% 19
2016
Q3
$51.6M Sell
1,627,647
-114,188
-7% -$3.82M 0.77% 16
2016
Q2
$57.9M Buy
1,741,835
+171,043
+11% +$5.46M 0.87% 13
2016
Q1
$44.7M Sell
1,570,792
-83,370
-5% -$2.38M 0.65% 19
2015
Q4
$51.4M Sell
1,654,162
-82,155
-5% -$2.58M 0.77% 14
2015
Q3
$51.3M Buy
1,736,317
+448,984
+35% +$14.4M 0.78% 16
2015
Q2
$41M Buy
1,287,333
+291,836
+29% +$9.51M 0.57% 25
2015
Q1
$33M Buy
995,497
+13,002
+1% +$413K 0.41% 40
2014
Q4
$29.2M Sell
982,495
-6,741
-0.7% -$193K 0.38% 44
2014
Q3
$27.9M Sell
989,236
-38,935
-4% -$1.09M 0.39% 43
2014
Q2
$28.9M Sell
1,028,171
-166,386
-14% -$4.74M 0.43% 40
2014
Q1
$36.2M Sell
1,194,557
-139,015
-10% -$4.14M 0.57% 34
2013
Q4
$38.8M Sell
1,333,572
-102,431
-7% -$2.98M 0.6% 27
2013
Q3
$39.3M Sell
1,436,003
-8,024
-0.6% -$218K 0.59% 27
2013
Q2
$38.6M Buy
+1,444,027
New +$39.9M 0.63% 26

Other funds holding PFE

Asset Management One's PFE Position: Q1 2026 in Review

Asset Management One reduced its Pfizer (PFE) stake by 5.4% in Q1 2026, selling an estimated $3.98M and leaving 2,590,740 shares worth $72.7M. The position accounts for 0.21% of the portfolio, ranked #86.

Asset Management One first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $450M in Q3 2018. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Asset Management One held 2,590,740 shares of Pfizer worth $72.7M as of Q1 2026.
  • Asset Management One sold 149,313 Pfizer shares in Q1 2026, an estimated $3.98M.
  • Pfizer made up 0.21% of Asset Management One's portfolio in Q1 2026, its #86 holding.
  • Asset Management One first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Asset Management One's Pfizer position peaked at $450M in Q3 2018.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Asset Management One's 13F filing for Q1 2026, filed 8 May 2026.